Market Vectors Pharmaceutical ETF (PPH) Short Interest Update

Share on StockTwits

Market Vectors Pharmaceutical ETF (NYSEARCA:PPH) was the target of a large growth in short interest during the month of July. As of July 31st, there was short interest totalling 1,886,699 shares, a growth of 97.1% from the July 13th total of 957,091 shares. Based on an average daily trading volume, of 26,164 shares, the days-to-cover ratio is presently 72.1 days.

Institutional investors have recently made changes to their positions in the company. Jaffetilchin Investment Partners LLC purchased a new stake in shares of Market Vectors Pharmaceutical ETF during the 2nd quarter valued at $455,000. Royal Bank of Canada increased its position in shares of Market Vectors Pharmaceutical ETF by 8.2% during the 1st quarter. Royal Bank of Canada now owns 12,208 shares of the company’s stock valued at $694,000 after purchasing an additional 920 shares during the last quarter. Mutual Advisors LLC purchased a new stake in shares of Market Vectors Pharmaceutical ETF during the 1st quarter valued at $823,000. Citadel Advisors LLC increased its position in shares of Market Vectors Pharmaceutical ETF by 11.2% during the 1st quarter. Citadel Advisors LLC now owns 19,478 shares of the company’s stock valued at $1,105,000 after purchasing an additional 1,966 shares during the last quarter. Finally, Virtu Financial LLC increased its position in shares of Market Vectors Pharmaceutical ETF by 255.6% during the 2nd quarter. Virtu Financial LLC now owns 34,244 shares of the company’s stock valued at $2,020,000 after purchasing an additional 24,614 shares during the last quarter.

Shares of Market Vectors Pharmaceutical ETF opened at $61.78 on Monday, Marketbeat Ratings reports. Market Vectors Pharmaceutical ETF has a 1 year low of $53.83 and a 1 year high of $64.65.

Further Reading: How to Track your Portfolio in Google Finance

Receive News & Ratings for Market Vectors Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Market Vectors Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply